Víctor Manuel González

Leads the Aptamer Group at the Ramón y Cajal Institute for Health Research (IRYCIS) focused on the selection and characterization of aptamers to be used in the development of diagnostic systems and/or therapeutic. In 2010 he co-founded Aptus Biotech and is currently the company’s COO.